Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 89

Optimizing Deep Brain Stimulation for Parkinson's Disease Gait Issues

Official title: Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder

Run by University of Minnesota · NCT05893186 · Data updated 2026-11-12

This study is testing if adjusting brain stimulation settings can help people with Parkinson's disease walk better and improve their balance.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedMay 25, 2021
Main results expectedJuly 15, 2029
Study endsDecember 31, 2029
Registry record updatedMay 8, 2026
Trial IDNCT05893186 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with Parkinson's disease who have undergone bilateral deep brain stimulation and meet specific imaging and timing criteria.

Probably not a fit

Patients with significant neurological or musculoskeletal disorders affecting movement, dementia, or those who have had prior neurosurgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves sixty patients with Parkinson's disease who are receiving bilateral deep brain stimulation (DBS) to improve their gait and balance. Using advanced imaging techniques, including 7 Tesla MRI and postoperative CT scans, researchers will create patient-specific models to optimize DBS settings. The goal is to selectively activate specific neural pathways associated with gait and balance, comparing different stimulation settings to determine the most effective approach. Participants will undergo testing to measure improvements in gait, balance, bradykinesia, and rigidity.

Why it matters

Potential benefit: If successful, this approach could lead to more effective and personalized treatment options for patients with Parkinson's disease, improving their mobility and quality of life.

How similar studies have gone: While this approach is innovative, similar studies using advanced imaging and personalized stimulation settings have shown promise in improving outcomes for patients with movement disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of PD
* Bilateral DBS
* Directional DBS electrode system
* MRI, at least 7 Tesla, with diffusion tensor imaging, prior to DBS surgery
* Head CT, at least 1mm cuts, following DBS surgery
* At least 3 months since initial activation of the neurostimulator

Exclusion Criteria:

* Neurological or musculoskeletal disorder that significantly affects gait, balance, or limb movements
* Dementia
* Prior stereotactic neurosurgery other than DBS for movement disorder
* Pregnancy

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Scott Cooper, MD, PhD — University of Minnesota
  • Study coordinator: Johanna Caskey, BA
  • Email: caske039@umn.edu
  • Phone: 763-353-9470

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.